Context Therapeutics Inc. · NASDAQ:CNTX
Deep Track Capital, LP reported a 8.27% stake in Context Therapeutics Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
Deep Track Capital, LP reported a 8.27% stake in Context Therapeutics Inc., 7,419,355 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 8.27%
- Shares
- 7,419,355
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 8.27% | 7,419,355 |
| Deep Track Biotechnology Master Fund, Ltd. | 8.27% | 7,419,355 |
| David Kroin | 8.27% | 7,419,355 |
Source
Related
- Context Therapeutics Inc.
- Deep Track Capital, LP
- Context Therapeutics Inc. shareholders
- Schedule 13G/A · Mpm Bioimpact LLC · Aug 14, 2026
- Schedule 13G/A · Blue Owl Capital Holdings LP · Aug 12, 2026
- Schedule 13G/A · Octagon Capital Advisors LP · Jul 31, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · Great Point Partners LLC · May 15, 2026